In summary, the application of cMDSCs propagated from GM-CSF, IL-6, and IL-1β cytokines can improve renal function and increase insulin secretion from pancreatic islets, thereby prolonging the diabetes-free survival of NOD–SCID mice after treatment with T cells (Figure 3h). This evidence concerns the gene CSF2 and diabetes mellitus.